# Association Between Effectiveness of Mirikizumab and UC Patients With High Neutrophilic Infiltration in Epithelium of the Colonic Mucosa

> **NCT06626165** · PHASE4 · COMPLETED · sponsor: **Showa Inan General Hospital** · enrollment: 100 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** Mirikizumab
- **DRUG:** Vedolizumab

## Key facts

- **NCT ID:** NCT06626165
- **Lead sponsor:** Showa Inan General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-20
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-09-30
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06626165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06626165, "Association Between Effectiveness of Mirikizumab and UC Patients With High Neutrophilic Infiltration in Epithelium of the Colonic Mucosa". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06626165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*